Homology Medicines Inc

NASDAQ:FIXX   3:59:52 PM EDT
5.17
-0.05 (-0.96%)
Earnings Announcements

Homology Medicines Reports Third Quarter 2021 Financial Results And Recent Highlights

Published: 11/15/2021 12:46 GMT
Homology Medicines Inc (FIXX) - Homology Medicines Reports Third Quarter 2021 Financial Results and Recent Highlights.
Q3 Loss per Share $0.54.
Continues to Expect Cash Resources to Fund Operations Into Q1 of 2023.
Q3 Earnings per Share View $-0.60 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.85 Million
Adjusted EPS is expected to be -$0.58

Next Quarter Revenue Guidance is expected to be $1.1 Million
Next Quarter EPS Guidance is expected to be -$0.60

More details on our Analysts Page.